Sieve estimation in a Markov illness-death process under dual censoring.
暂无分享,去创建一个
[1] D. Schoenfeld,et al. A joint test for progression and survival with interval‐censored data from a cancer clinical trial , 2014, Statistics in medicine.
[2] G. Hortobagyi,et al. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group. , 1996, The New England journal of medicine.
[3] Ørnulf Borgan,et al. Counting process models for life history data: a review , 1984 .
[4] A. Boruvka,et al. A Cox‐Aalen Model for Interval‐censored Data , 2015 .
[5] D. Rubin,et al. Ignorability and Coarse Data , 1991 .
[6] Jian Huang,et al. Sieve Estimation for the Proportional-Odds Failure-Time Regression Model with Interval Censoring , 1997 .
[7] James M. Robins,et al. Coarsening at Random: Characterizations, Conjectures, Counter-Examples , 1997 .
[8] A. Boruvka,et al. Bias in progression‐free survival analysis due to intermittent assessment of progression , 2015, Statistics in medicine.
[9] B. Turnbull. The Empirical Distribution Function with Arbitrarily Grouped, Censored, and Truncated Data , 1976 .
[10] J. Neyman,et al. A simple stochastic model of recovery, relapse, death and loss of patients. , 1951, Human biology.
[11] Halina Frydman,et al. Nonparametric estimation of a Markov ‘illness-death’ process from interval-censored observations, with application to diabetes survival data , 1995 .
[12] Christopher H. Jackson,et al. Multi-State Models for Panel Data: The msm Package for R , 2011 .
[13] Jian Huang,et al. A Spline‐Based Semiparametric Maximum Likelihood Estimation Method for the Cox Model with Interval‐Censored Data , 2010 .
[14] Andrew C Titman,et al. Flexible Nonhomogeneous Markov Models for Panel Observed Data , 2011, Biometrics.
[15] Daniel Commenges,et al. A penalized likelihood approach for an illness-death model with interval-censored data: application to age-specific incidence of dementia. , 2002, Biostatistics.
[16] A. Tsiatis,et al. Efficient estimation of the distribution of time to composite endpoint when some endpoints are only partially observed , 2013, Lifetime data analysis.
[17] Katherine S Panageas,et al. When you look matters: the effect of assessment schedule on progression-free survival. , 2007, Journal of the National Cancer Institute.
[18] P. Grambsch,et al. A Package for Survival Analysis in S , 1994 .
[19] D. Cox. Regression Models and Life-Tables , 1972 .
[20] A. Howell,et al. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial. , 2001, Cancer journal.
[21] Qiqing Yu,et al. Generalized MLE of a Joint Distribution Function with Multivariate Interval-Censored Data , 1999 .
[22] H. Frydman. Semiparametric estimation in a three-state duration-dependent Markov model from interval-censored observations with application to AIDS data. , 1995, Biometrics.
[23] A. W. van der Vaart,et al. On Profile Likelihood , 2000 .
[24] Jinfeng Xu,et al. Statistical Analysis of Illness–Death Processes and Semicompeting Risks Data , 2010, Biometrics.
[25] Halina Frydman,et al. Nonparametric Estimation in a Markov “Illness–Death” Process from Interval Censored Observations with Missing Intermediate Transition Status , 2009, Biometrics.
[26] A. Tsodikov,et al. Joint modeling approach for semicompeting risks data with missing nonterminal event status , 2014, Lifetime data analysis.
[27] D.,et al. Regression Models and Life-Tables , 2022 .
[28] Rebecca A. Betensky,et al. Local Likelihood Analysis of Survival Data With Censored Intermediate Events , 2001 .